Evidence map›Paper›PMID 33980276›Full record

ArticleClinical epigenetics2021

Ultralow amounts of DNA from long-term archived serum samples produce high-quality methylomes.

Marcin W Wojewodzic, Magnus Leithaug, Marianne Lauritzen, Robert Lyle, Sofia Haglund, Carl-Johan Rubin, Philip A Ewels, Tom Grotmol, Trine B Rounge

Open access · goldAbstract read
In one paragraph

Article in Clinical epigenetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Marcin W WojewodzicDepartment of Research, Cancer Registry of Norway, Oslo, Norway. Marcin.Wojewodzic@kreftregisteret.no.ORCID 0000-0003-2501-5201
Magnus LeithaugDepartment of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
Marianne LauritzenDepartment of Research, Cancer Registry of Norway, Oslo, Norway.
Robert LyleDepartment of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
Sofia HaglundScience for Life Laboratory (SciLifeLab), Department of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden.
Carl-Johan RubinDepartment of Medical Biochemistry and Microbiology, Uppsala University, 75123, Uppsala, Sweden.
Philip A EwelsScience for Life Laboratory (SciLifeLab), Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Tom GrotmolDepartment of Research, Cancer Registry of Norway, Oslo, Norway.
Trine B RoungeDepartment of Research, Cancer Registry of Norway, Oslo, Norway.ORCID 0000-0003-2677-2722
Cancer Registry of Norway · NOOslo University Hospital · NOScience for Life Laboratory · SEStockholm University · SEUniversity of Oslo · NOUppsala University · SE

Funding

Kreftforeningen 190157-2017
6 · The paper itself

Abstract

backgroundLong-term stored serum is considered challenging for epigenomic analyses: as there are no cells, circulating DNA is scarce, and amplification removes epigenetic signals. Additionally, pre-analytical treatments and storage might introduce biases and fragmentation to the DNA. In particular, starting with low-input DNA can result in low-diversity libraries. However, successful whole-genome bisulphite sequencing (WGBS) of such serum samples has the potential to open biobanks for epigenetic analyses and deliver novel prediagnostic biomarkers. Here, we perform WGBS using the Accel-NGS library preparation kit on ultralow amounts of DNA from long-term archived samples with diverse pretreatments from the Janus Serum Bank.

resultsNinety-four of the 96 samples produced satisfactory methylation calls; an average of 578 M reads per sample generated a mean coverage of 17× and mean duplication level of 35%. Failed samples were related to poor bisulphite conversion rather than to sequencing or library preparation. We demonstrate the feasibility of WGBS on ultralow DNA yields from serum samples stored up to 48 years.

conclusionsOur results show the potential of large serum biobank collections for future epigenomic studies and biomarker discovery.

Indexed as

Blood BankingBlood BanksDNA MethylationEpigenomeEpigenomicsHigh-Throughput Nucleotide SequencingHumansReproducibility of ResultsTimeWhole Genome SequencingBiobanksEpigeneticsMethodsMethylomeSerumStorageWGBS

Identifiers

PMID33980276
PMCPMC8114536
OpenAlexW3161070342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.